2026 ASCO Direct™ GI

 

Total Health’s 2026 ASCO Direct™ Gastrointestinal Cancer Conference is an officially licensed ASCO Direct™ meeting. This Post-ASCO Gastrointestinal Cancers Symposium Review highlights key abstracts from top-rated presentations, providing attendees with direct access to the latest research and strategies in GI oncology education. The accredited meeting will be hosted as an in-person meeting only available exclusively to registered participants.

Event Page

 

Accreditation Information | 6.00

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
  • Amedco LLC designates this activity for a maximum of 6.00 ANCC contact hours.

  • Amedco LLC designates this live activity for a maximum of 6.00 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Amedco LLC designates this activity for a maximum of 6.00 knowledge-based CPE contact hours.

    JA4008163-9999-26-021-L01-P | JA4008163-9999-26-021-L01-T

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.

  • Disclosure of Conflict of Interest

    The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5) All individuals in a position to control the content of CE are listed below.

    Christopher Cann - Taiho Pharmaceuticals, Regeneron: Consultant Taiho Pharmaceuticals:Scientific/Medical Advisory Board Member
    Haley Ellis - AstraZeneca, Jazz Pharmaceuticals:Scientific/Medical Advisory Board Member, Cogent Biosciences, AstraZeneca, Scitaris: Consultant Incyte: Other Boehringer Ingelheim:Research Grant Overall Principal Investigator
    Michael Hall - NA
    Aiwu Ruth He - Astrazeneca, Eisai:Speakers Bureau
    Gregory Heestand - AstraZeneca, Eisai Pharmaceuticals, Elevar Therapeutics, Exelixis:Consultant Genentech:Other
    Nicholas Hornstein - Caper Labs, BMS:Consultant, Incyte, Pfizer, Boston Scientific:Scientific/Medical Advisory Board Member Histosonics, Exelixis:Research Grant Overall Principal Investigator
    Sunnie Kim - BMS, Daiichi Sankyo, Astrazeneca,Gilead:Scientific/Medical Advisory Board Member Merck:Research Grant Overall Principal Investigator Amgen:Consultant
    Kelsey Lau-Min NA
    Daniel Lin - Exelixis, Genentech, Bristol Myers Squibb, Agenus, Incyte, AstraZeneca:Consultant
    ARTURO LOAIZA-BONILLA - Guardant, Ipsen, Natera, AstraZeneca:Speakers BureauVerily (Google/Alphabet),MedScape/WebMD, PSI CRO, Bayer, Astra-Zeneca, Cardinal Health, BrightInsight, The Lynx Group, Fresenius, Merck, Pfizer,Science37:ConsultantBioLineRx:Public Stock ShareholderMassive Bio:Private Stock Shareholder
    Midhun Malla - Exelixis , Natera , Merus , BMS, Astrazenaca, Astellas:Consultant Incyte , Taiho Oncology:Speakers Bureau
    Steven Maron - Pinetree Therapeutics, Bolt Biotherapeutics, Amgen, Elevation Oncology, Everest Medicine:Consultant Paige.AI:Research Grant Overall Principal Investigator Purple Oncology, 1Cell.Dx:Scientific/Medical Advisory Board Member
    Kim Reiss - Guardant, Foundation Medicine, MOMA Therapeutics, Synovation Bio, Merus:Consultant
    Rachael Safyan - Guardant Health, Mirati Therapeutics, Agenus, Ipsen:Consultant
    Benjamin Weinberg - Apple Inc.:Public Stock Shareholder Primum:Consultant Jazz Pharmaceuticals, AstraZeneca/Daiichi Sankyo, Merus NV, DoMore Diagnostics, CytoDyn, Agenus,Regeneron:Scientific/Medical Advisory BoardMemberNatera, Caris Life Sciences, Pfizer:Speakers Bureau
    Arthur Winer - Gilead, Astrazeneca:Scientific/Medical Advisory Board Member Abbott Labs, Baxter, J&J:Public Stock Shareholder
    Nelson Yee - NA
    Reyna Wilhelm - NA
    Justin Kaiser - NA

 
 

How to Get Your Certificate

Go to thc.cmecertificateonline.com

Evaluate the meeting.

Print, download, or save your certificate for your records.

If you lose your certificate, or need help, go to help.cmecertificateonline.com

 
Previous
Previous

2026 Cancer Updates GI & Breast, Dallas

Next
Next

2026 West Oncology Conference